India's equity benchmarks opened lower on Friday, weighed by a pullback in IT and pharma stocks, while hopes of a proposed ...

Pharmaceuticals Export Promotion Council of India (Pharmexcil) has said that the US will take 3-5 years to build enough ...

The broader small-caps and mid-caps fell 0.4% and 0.7%, respectively.U.S.-exposed IT stocks shed 0.9%, while the pharma index ...

U.S. President Donald Trump imposed an additional 25% tariff on goods imported from India this week, citing New Delhi's ...

Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly ...

In FY24, India exported $8.7 billion (Rs76,113 crore) worth of pharmaceutical products to the US, while importing around $800 ...

The Indian pharmaceutical industry has been excluded from the United States' latest round of tariff hikes, with Washington ...

President Donald Trump said he’d impose increased tariffs on countries buying energy from Russia while clarifying that levies ...

Indian pharma companies will need to change tack and find newer markets should the Trump administration impose a reciprocal ...

Indian pharmaceutical exports have narrowly escaped the brunt of US President Donald Trump’s latest tariff salvo, which ...

Pharmexcil warns US tariffs on Indian pharmaceuticals would harm American consumers. India is a key supplier of affordable ...

President Trump announces steep new tariffs: 50% on Indian goods, 15% on Japan, 100% on semiconductors, and up to 250% on ...